Seminars in Radiation Oncology
Volume 18, Issue 4 , Pages 223-228, October 2008

Clinical Experience Shows That Catastrophic Late Effects Associated With Ablative Fractionation Can Be Avoided by Technological Innovation

  • Brian Kavanagh, MD, MPH

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Brian Kavanagh, MD, MPH, Department of Radiation Oncology, University of Colorado Denver, Campus Mail Stop F706, 1665 N Ursula St, Suite 1032, PO Box 6510, Aurora, CO 80045

Department of Radiation Oncology, University of Colorado Denver, Aurora, CO

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1053-4296(08)00031-3

doi:10.1016/j.semradonc.2008.04.002

Seminars in Radiation Oncology
Volume 18, Issue 4 , Pages 223-228, October 2008

Article Tools